Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Summary

This is a Phase 2a, randomized, double blind, vehicle controlled, parallel group, proof of concept study that will include participants with stasis dermatitis without active skin ulceration, who will receive crisaborole ointment 2% or vehicle twice daily for 6 weeks.

Timeline

Start

2020-06-26

Primary completion

2021-10-19

Completion

2021-10-19

Drugs

Indications